CVS Health Corp, the biggest provider of prescription drugs in the US. posted third-quarter earnings that matched analysts’ estimates as sales grew in the company’s prescription drugs management business as well as its retail pharmacies.
Profit excluding one-time items of $1.29 a share equaled an average of analysts’ estimates compiled by Bloomberg. Sales rose 10 percent from a year earlier to $38.6 billion. Analysts had projected $38.2 billion.
More to follow...
News by Bloomberg, edited by ESM. To subscribe to ESM: The European Supermarket Magazine, click here.